Perfromance Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Perfromance Wealth Partners's AMGN Position: Q3 2026 in Review
Perfromance Wealth Partners reduced its Amgen (AMGN) stake by 10% in Q3 2026, selling an estimated $122K and leaving 2,672 shares worth $1.13M. The position accounts for 0.03% of the portfolio, ranked #89.
Perfromance Wealth Partners first reported a position in AMGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $8.61M in Q4 2023. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Perfromance Wealth Partners held 2,672 shares of Amgen worth $1.13M as of Q3 2026.
- Perfromance Wealth Partners sold 307 Amgen shares in Q3 2026, an estimated $122K.
- Amgen made up 0.03% of Perfromance Wealth Partners's portfolio in Q3 2026, its #89 holding.
- Perfromance Wealth Partners first reported a position in Amgen in Q4 2021 and has held it in 20 quarters since.
- Perfromance Wealth Partners's Amgen position peaked at $8.61M in Q4 2023.
- 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Perfromance Wealth Partners's 13F filing for Q3 2026, filed 12 Nov 2026.